Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics' Q3 Revenues Climb on ResponseDx Uptick

NEW YORK (GenomeWeb News) – Response Genetics reported after the close of the market Monday that its third-quarter revenues increased 15 percent as sales of its ResponseDx tests rose sharply quarter to quarter.

The Los Angeles-based molecular diagnostics firm brought in total revenues of $2.3 million for the three-month period ended Sept. 30, compared to $2 million for the third quarter of 2008. It said that revenues from its ResponseDx: Lung and ResponseDx: Colon tests, which were launched in the third quarter of 2008, more than doubled compared to the second quarter of 2009.

"This increase was driven by the rapid adoption of our diagnostic tests by oncologists and the addition of EGFR mutational analysis to the ResponseDX: Lung panel," Kathleen Danenberg, Response Genetics' president and CEO, said in a statement. "This addition doubled our reimbursement from payors from approximately $1,000 to $1,950."

The firm also recently launched its ResponseDx: Gastric panel, which helps physicians make treatment decisions for patients with gastric and gastroesophageal junction cancer.

Response Genetics' net loss declined 9 percent year over year to $2 million, or $.14 per share, from $2.2 million, or $.21 per share.

Its R&D expenses increased to $726,696 from $410,469, while its SG&A spending increased to $2.2 million from $2.1 million.

Response Genetics reported cash and cash equivalents of $9.3 million as of the end of the third quarter.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.